Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cce9fea7c6c927f12f44fee11fe27f1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
filingDate |
2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e61fcc22e5e6c27a09ea7a3b1da4c37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d833d3646cbd344edd47224699d6aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05ea5d489b2de72b02a20899bad132c0 |
publicationDate |
2013-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013273011-A1 |
titleOfInvention |
Stem cells and stem cell generated nanoparticles for treatment of inflammatory conditions and acute radiation syndrome |
abstract |
Disclosed are stem cells and nanoparticles derived from said stem cells, useful for the treatment of acute radiation syndrome (ARS) and other inflammatory conditions. In one embodiment, Endometrial Regenerative Cells (ERC) are administered to patients having been exposed to radiation to augment recovery of endogenous hematopoietic stem cells. In another embodiment, exosomes, nanoparticles that are generated by various stem cells are used as a drug for treatment of inflammatory conditions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019053224-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10472609-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10167448-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112469423-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040071-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017064647-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10829739-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015088286-A1 |
priorityDate |
2012-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |